Vertex Pharmaceuticals, Inc’s recent filing unveils that its EVP, Chief Scientific Officer ALTSHULER DAVID unloaded Company’s shares for reported $7178.0 on Nov 15 ’24. In the deal valued at $478.56 per share,15 shares were sold. As a result of this transaction, ALTSHULER DAVID now holds 25,813 shares worth roughly $10.55 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, ALTSHULER DAVID bought 15 shares, generating $7,178 in total proceeds.
Before that, WAGNER CHARLES F JR sold 3,000 shares. Vertex Pharmaceuticals, Inc shares valued at $1,554,810 were divested by the EVP & Chief Financial Officer at a price of $518.27 per share. As a result of the transaction, WAGNER CHARLES F JR now holds 44,137 shares, worth roughly $18.04 million.
H.C. Wainwright reiterated its Vertex Pharmaceuticals, Inc [VRTX] rating to a Buy in a research note published on December 20, 2024; the price target was $535. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who decreased its forecast for the stock in mid December from “an Outperform” to “a Perform”. Jefferies also remained covering VRTX and has increased its forecast on December 09, 2024 with a “Buy” recommendation from previously “Hold” rating. Citigroup started covering the stock on November 14, 2024. It rated VRTX as “a Buy”.
Price Performance Review of VRTX
On Friday, Vertex Pharmaceuticals, Inc [NASDAQ:VRTX] saw its stock fall -0.46% to $408.76. Over the last five days, the stock has gained 3.06%. Vertex Pharmaceuticals, Inc shares have risen nearly 0.46% since the year began. Nevertheless, the stocks have risen 0.17% over the past one year. While a 52-week high of $519.88 was reached on 11/08/24, a 52-week low of $377.85 was recorded on 12/19/24. SMA at 50 days reached $464.67, while 200 days put it at $457.54.
Levels Of Support And Resistance For VRTX Stock
The 24-hour chart illustrates a support level at 405.17, which if violated will result in even more drops to 401.59. On the upside, there is a resistance level at 411.66. A further resistance level may holdings at 414.57. The Relative Strength Index (RSI) on the 14-day chart is 31.70, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -30.16, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 68.65%. Stochastics %K at 31.79% indicates the stock is a holding.
How much short interest is there in Vertex Pharmaceuticals, Inc?
A steep rise in short interest was recorded in Vertex Pharmaceuticals, Inc stocks on 2024-12-13, dropping by -0.6 million shares to a total of 3.51 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 4.11 million shares. There was a decline of -17.03%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on October 16, 2024 when Scotiabank began covering the stock and recommended ‘”a Sector perform”‘ rating .
